FFA
EBS icon

Farther Finance Advisors’s Emergent Biosolutions EBS Stock Holding History

Farther Finance Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.5K Buy
2,648
+561
+27% +$3.68K ﹤0.01% 4243
2026
Q2 		$17.5K Sell
2,087
-377
-15% -$3.15K ﹤0.01% 4071
2026
Q1 		$20.6K Sell
2,464
-3,699
-60% -$38.3K ﹤0.01% 3632
2025
Q4 		$76.2K Buy
6,163
+4,827
+361% +$51.7K ﹤0.01% 2520
2025
Q3 		$11.8K Buy
1,336
+861
+181% +$6.7K ﹤0.01% 3371
2025
Q2 		$3.03K Sell
475
-3,195
-87% -$18.3K ﹤0.01% 3551
2025
Q1 		$17.4K Buy
3,670
+3,175
+641% +$26.3K ﹤0.01% 2455
2024
Q4 		$4.73K Sell
495
-60
-11% -$551 ﹤0.01% 2694
2024
Q3 		$4.63K Sell
555
-69
-11% -$627 ﹤0.01% 2680
2024
Q2 		$4.41K Buy
624
+136
+28% +$585 ﹤0.01% 2452
2024
Q1 		$1.12K Buy
488
+39
+9% +$88 ﹤0.01% 2726
2023
Q4 		$1.08K Buy
449
+429
+2,145% +$1.01K ﹤0.01% 2695
2023
Q3 		$68 Hold
20
– – ﹤0.01% 2559
2023
Q2 		$147 Hold
20
– – ﹤0.01% 2399
2023
Q1 		$207 Sell
20
-24
-55% -$290 ﹤0.01% 2193
2022
Q4 		$520 Buy
+44
New +$681 ﹤0.01% 1824

Other funds holding EBS

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Farther Finance Advisors's EBS Position: Q3 2026 in Review

Farther Finance Advisors increased its Emergent Biosolutions (EBS) stake by 27% in Q3 2026, buying an estimated $3.68K and bringing the position to 2,648 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4243.

Farther Finance Advisors first reported a position in EBS in Q4 2022 and has held it in 16 quarters since. The position peaked at $76.2K in Q4 2025. 7 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Farther Finance Advisors held 2,648 shares of Emergent Biosolutions worth $17.5K as of Q3 2026.
  • Farther Finance Advisors bought 561 Emergent Biosolutions shares in Q3 2026, an estimated $3.68K.
  • Emergent Biosolutions made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4243 holding.
  • Farther Finance Advisors first reported a position in Emergent Biosolutions in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Emergent Biosolutions position peaked at $76.2K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.